Concepedia

Shiming Ye

SY

Statistics

Publications

10

Citations

1.2K

H-Index

10

Active since

2004

Affiliations

AbbVie (United States)(Current)

Gladstone Institutes

University of California, San Francisco

Merck & Co., Inc., Rahway, NJ, USA (United States)

Shiming Ye is an author at AbbVie (United States) specializing in life sciences, immunology, and cancer immunotherapy.

ORCID

Publications per year

2004–2021

10

Publications

10

Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy

Qian Gong, Qinglin Ou, Shiming Ye et al. · The Journal of Immunology · 2005 · 540 citations · Full text

, , +16

Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target

Shiming Ye, Yadong Huang, Karin Müllendorff et al. · Proceedings of the National Academy of Sciences · 2005 · 264 citations · Full text

, , +17

Identification of Cathepsin B as a Mediator of Neuronal Death Induced by Aβ-activated Microglial Cells Using a Functional Genomics Approach

Li Gan, Shiming Ye, Alan Chu et al. · Journal of Biological Chemistry · 2004 · 126 citations · Full text

, , +17

Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors

Jason J. Luke, Fabrice Barlési, Ki Y. Chung et al. · Journal for ImmunoTherapy of Cancer · 2021 · 60 citations · Full text

, , +17

Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade

Wei Lin, Qian Gong, Dhaya Seshasayee et al. · Blood · 2007 · 58 citations · Full text

, , +16

1–5 of 10